Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

BIO Europe

posted on Oct 28, 2018 08:34AM

FYI, Resverlogix and Zenith are on the BIO Europe presentation schedule for Tuesday November 6 at 17:00 and 9:30 Copenhagen time, respectively.

3 Recommendations

Re: BIO Europe

BearDownAZ

Nov 05, 2018 12:32PM

Reply New Message

Back To Forum List View

Please to post a reply